Non-alcoholic Fatty Liver Disease
"Non-alcoholic Fatty Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fatty liver finding without excessive ALCOHOL CONSUMPTION.
|Non-alcoholic Fatty Liver Disease
- Non-alcoholic Fatty Liver Disease
- Non alcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease
- Fatty Liver, Nonalcoholic
- Fatty Livers, Nonalcoholic
- Liver, Nonalcoholic Fatty
- Livers, Nonalcoholic Fatty
- Nonalcoholic Fatty Liver
- Nonalcoholic Fatty Livers
- Nonalcoholic Steatohepatitis
- Nonalcoholic Steatohepatitides
- Steatohepatitides, Nonalcoholic
- Steatohepatitis, Nonalcoholic
Below are MeSH descriptors whose meaning is more general than "Non-alcoholic Fatty Liver Disease".
Below are MeSH descriptors whose meaning is more specific than "Non-alcoholic Fatty Liver Disease".
This graph shows the total number of publications written about "Non-alcoholic Fatty Liver Disease" by people in this website by year, and whether "Non-alcoholic Fatty Liver Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Non-alcoholic Fatty Liver Disease" by people in Profiles.
Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
Maternal Western diet is associated with distinct preclinical pediatric NAFLD phenotypes in juvenile nonhuman primate offspring. Hepatol Commun. 2023 Feb 01; 7(2):e0014.
Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease. J Pharmacol Exp Ther. 2022 10; 383(1):32-43.
Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD. Int J Mol Sci. 2022 May 27; 23(11).
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis. Hepatology. 2021 04; 73(4):1290-1306.
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress. Free Radic Biol Med. 2021 02 20; 164:315-328.
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients. 2020 Oct 16; 12(10).
Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights. Am J Surg Pathol. 2020 10; 44(10):1406-1412.
The effect of sleep on gastrointestinal functioning in common digestive diseases. Lancet Gastroenterol Hepatol. 2020 06; 5(6):616-624.